Moderna, Inc., (NASDAQ:MRNA) a clinical stage biotechnology company
pioneering messenger RNA (mRNA) therapeutics and vaccines to create a
new generation of transformative medicines for patients, today announced
that Tal Zaks, M.D., Ph.D., Moderna’s Chief Medical Officer, will
participate in a fireside chat at the 18th Annual Needham
Healthcare Conference on Wednesday, April 10, 2019 at 11:20 a.m. ET.
pioneering messenger RNA (mRNA) therapeutics and vaccines to create a
new generation of transformative medicines for patients, today announced
that Tal Zaks, M.D., Ph.D., Moderna’s Chief Medical Officer, will
participate in a fireside chat at the 18th Annual Needham
Healthcare Conference on Wednesday, April 10, 2019 at 11:20 a.m. ET.
A live webcast of the presentation will be available under “Events and
Presentations” in the Investors section of the Moderna website at https://investors.modernatx.com/.
A replay of the webcast will be archived on Moderna’s website for 30
days following the presentation.
Presentations” in the Investors section of the Moderna website at https://investors.modernatx.com/.
A replay of the webcast will be archived on Moderna’s website for 30
days following the presentation.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.